We are moving into the next phase of review for . To keep our timeline on track, please address the following by Friday:
Any adverse events (AEs) noted during the screening window must be logged immediately. 1GTX019
Ensure the intracranial imaging (MRI/PET-CT) reports are uploaded to the secure portal. We are moving into the next phase of review for
Please reach out if you have any questions regarding the specific documentation required for this subject. Option 2: Corporate/Legal Case Management 1GTX019
Ensure the metadata for 1GTX019 matches our secondary tracking sheets to avoid reporting discrepancies.
Verify that all lab results align with the protocol’s inclusion/exclusion requirements (e.g., coagulation status and prior infusions).
Complete the audit of all attachments linked to this identifier.